Clinical trials
Peripheral Nervous System Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 3 |
| Recruiting | 2 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pharnext S.C.A. | 2 |
| University Health Network, Toronto | 2 |
| University of British Columbia | 2 |
| AHS Cancer Control Alberta | 1 |
| Baxalta now part of Shire | 1 |
| CancerCare Manitoba | 1 |
| Eli Lilly and Company | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| University of Alberta | 1 |
| University of Calgary | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Nervous System Diseases | 15 |
| Diabetes Mellitus | 4 |
| Breast Neoplasms | 3 |
| Charcot-Marie-Tooth Disease | 2 |
| Pain | 2 |
| Polyneuropathies | 2 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 |
| Autoimmune Diseases | 1 |
| Autoimmune Diseases of the Nervous System | 1 |
| Demyelinating Diseases | 1 |
Trials
Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.